• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人激肽释放酶hK2具有低激肽原酶活性,而前列腺特异性抗原(hK3)则没有。

Human kallikrein hK2 has low kininogenase activity while prostate-specific antigen (hK3) has none.

作者信息

Deperthes D, Marceau F, Frenette G, Lazure C, Tremblay R R, Dubé J Y

机构信息

Laboratory of Hormonal Bioregulation, CHUL Research Center and Laval University, Sainte-Foy, Quebec, Canada.

出版信息

Biochim Biophys Acta. 1997 Nov 14;1343(1):102-6. doi: 10.1016/s0167-4838(97)00135-0.

DOI:10.1016/s0167-4838(97)00135-0
PMID:9428664
Abstract

In the present paper, we determined the kinin-releasing activity of human prostatic kallikrein hK2 and compared it to one of the kallikreins hK1 and prostate specific antigen (hK3). Kinin-like substances active on the rabbit jugular vein were progressively produced when nanomolar concentrations of hK2 were incubated with heated plasma. However in these experiments, hK1 appeared much more potent than hK2 while hK3 was totally inactive. When hK2 was incubated with purified high molecular weight kininogen, several peptides were generated as shown by the analysis on C18 reverse-phase HPLC. Kinin activity was localized exclusively in a small peak having an elution time identical to that of bradykinin while the only important peak obtained with hK1 corresponded to Lys-bradykinin. Finally, the rate of kinin production of hK2 was found to be more than a thousandfold lower than that of hK1. These experiments show that kallikreins hK2 has only a low kininogenase activity. However, it is not excluded that some of the peptides produced by hK2 action could have other types of biological activity.

摘要

在本论文中,我们测定了人前列腺激肽释放酶hK2的激肽释放活性,并将其与激肽释放酶之一hK1以及前列腺特异性抗原(hK3)进行比较。当纳摩尔浓度的hK2与加热的血浆一起孵育时,对兔颈静脉有活性的类激肽物质会逐渐产生。然而,在这些实验中,hK1似乎比hK2更具活性,而hK3则完全无活性。当hK2与纯化的高分子量激肽原一起孵育时,通过C18反相高效液相色谱分析表明产生了几种肽。激肽活性仅定位在一个洗脱时间与缓激肽相同的小峰中,而用hK1得到的唯一重要峰对应于赖氨酰缓激肽。最后,发现hK2的激肽产生速率比hK1低一千多倍。这些实验表明,激肽释放酶hK2仅具有低激肽原酶活性。然而,不排除hK2作用产生的一些肽可能具有其他类型的生物活性。

相似文献

1
Human kallikrein hK2 has low kininogenase activity while prostate-specific antigen (hK3) has none.人激肽释放酶hK2具有低激肽原酶活性,而前列腺特异性抗原(hK3)则没有。
Biochim Biophys Acta. 1997 Nov 14;1343(1):102-6. doi: 10.1016/s0167-4838(97)00135-0.
2
Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.从精液中纯化得到的前列腺源性人腺体激肽释放酶(hK2)的激肽原酶活性。
J Androl. 1999 Mar-Apr;20(2):220-9.
3
Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2.用于研究人组织激肽释放酶hK1和hK2底物特异性的丝氨酸蛋白酶抑制剂衍生肽底物。
J Biol Chem. 1997 Nov 21;272(47):29590-5. doi: 10.1074/jbc.272.47.29590.
4
Immunohistochemical study suggesting a complementary role of kallikreins hK2 and hK3 (prostate-specific antigen) in the functional analysis of human prostate tumors.免疫组织化学研究表明激肽释放酶hK2和hK3(前列腺特异性抗原)在人类前列腺肿瘤功能分析中具有互补作用。
Am J Pathol. 1997 Feb;150(2):455-9.
5
Prostatic kallikrein hK2, but not prostate-specific antigen (hK3), activates single-chain urokinase-type plasminogen activator.前列腺激肽释放酶hK2可激活单链尿激酶型纤溶酶原激活剂,而前列腺特异性抗原(hK3)则不能。
Int J Cancer. 1997 May 29;71(5):897-9. doi: 10.1002/(sici)1097-0215(19970529)71:5<897::aid-ijc31>3.0.co;2-2.
6
Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate.人激肽释放酶2(hK2)和前列腺特异性抗原(PSA):前列腺中两种密切相关但又不同的激肽释放酶。
Crit Rev Clin Lab Sci. 1998 Aug;35(4):275-368. doi: 10.1080/10408369891234219.
7
T-kininogenase activity of the rat submandibular gland is predominantly due to the kallikrein-like serine protease antigen gamma.大鼠下颌下腺的T-激肽原酶活性主要归因于类激肽释放酶丝氨酸蛋白酶抗原γ。
Biochem J. 1991 Nov 15;280 ( Pt 1)(Pt 1):19-25. doi: 10.1042/bj2800019.
8
Association of kallikrein expression in nipple aspirate fluid with breast cancer risk.乳头抽吸液中激肽释放酶表达与乳腺癌风险的关联。
Int J Cancer. 2004 Feb 10;108(4):588-91. doi: 10.1002/ijc.11607.
9
Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2.人组织激肽释放酶2对前列腺特异性抗原酶原形式的激活作用。
Biochem Biophys Res Commun. 1997 Sep 18;238(2):549-55. doi: 10.1006/bbrc.1997.7333.
10
Polyclonal and monoclonal antibodies to prostate-specific antigen can cross-react with human kallikrein 2 and human kallikrein 1.针对前列腺特异性抗原的多克隆抗体和单克隆抗体可与人激肽释放酶2和人激肽释放酶1发生交叉反应。
Urology. 1999 Apr;53(4):746-51. doi: 10.1016/s0090-4295(98)00573-1.

引用本文的文献

1
Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging roles.前列腺特异性激肽释放酶相关肽酶及其与前列腺癌生物学和检测的关系。已确立的相关性和新出现的作用。
Thromb Haemost. 2013 Sep;110(3):484-92. doi: 10.1160/TH13-04-0275. Epub 2013 Aug 1.